Although IFN-γ plays an important role in cancer immune microenvironment, it also reportedly induces PD-L1 upregulation in several types of cancer.28 We firstly demonstrated those roles in GC treated by Tmab and our findings should have considerable clinical implications for accurate assessment of PD-L1 expression after Tmab treatment. The gene discussed is IFNG; the disease is cancer.